These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19749771)

  • 1. Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy.
    Chen YH; Chang M; Davidson BL
    Nat Med; 2009 Oct; 15(10):1215-8. PubMed ID: 19749771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gateway to the diseased brain.
    Mingozzi F; High KA
    Nat Med; 2009 Oct; 15(10):1123-4. PubMed ID: 19812565
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors.
    Liu G; Martins I; Wemmie JA; Chiorini JA; Davidson BL
    J Neurosci; 2005 Oct; 25(41):9321-7. PubMed ID: 16221840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease.
    Chen YH; Claflin K; Geoghegan JC; Davidson BL
    Mol Ther; 2012 Jul; 20(7):1393-9. PubMed ID: 22588273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS-directed gene therapy for lysosomal storage diseases.
    Sands MS; Haskins ME
    Acta Paediatr; 2008 Apr; 97(457):22-7. PubMed ID: 18339183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse.
    Sferra TJ; Qu G; McNeely D; Rennard R; Clark KR; Lo WD; Johnson PR
    Hum Gene Ther; 2000 Mar; 11(4):507-19. PubMed ID: 10724030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain.
    Cearley CN; Wolfe JH
    Mol Ther; 2006 Mar; 13(3):528-37. PubMed ID: 16413228
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Batista AR; King OD; Reardon CP; Davis C; Shankaracharya ; Philip V; Gray-Edwards H; Aronin N; Lutz C; Landers J; Sena-Esteves M
    Hum Gene Ther; 2020 Jan; 31(1-2):90-102. PubMed ID: 31696742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII.
    Karolewski BA; Wolfe JH
    Mol Ther; 2006 Jul; 14(1):14-24. PubMed ID: 16624622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal gene therapy reduces lysosomal storage in specific areas of the CNS in mucopolysaccharidosis VII mice.
    Hennig AK; Levy B; Ogilvie JM; Vogler CA; Galvin N; Bassnett S; Sands MS
    J Neurosci; 2003 Apr; 23(8):3302-7. PubMed ID: 12716937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice.
    Passini MA; Watson DJ; Vite CH; Landsburg DJ; Feigenbaum AL; Wolfe JH
    J Virol; 2003 Jun; 77(12):7034-40. PubMed ID: 12768022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors.
    Bosch A; Perret E; Desmaris N; Heard JM
    Mol Ther; 2000 Jan; 1(1):63-70. PubMed ID: 10933913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors.
    Brooks AI; Stein CS; Hughes SM; Heth J; McCray PM; Sauter SL; Johnston JC; Cory-Slechta DA; Federoff HJ; Davidson BL
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6216-21. PubMed ID: 11959904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated virus type 5 reduces learning deficits and restores glutamate receptor subunit levels in MPS VII mice CNS.
    Liu G; Chen YH; He X; Martins I; Heth JA; Chiorini JA; Davidson BL
    Mol Ther; 2007 Feb; 15(2):242-7. PubMed ID: 17235300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy.
    Chen Y; Zheng S; Tecedor L; Davidson BL
    Mol Ther; 2018 Apr; 26(4):1118-1126. PubMed ID: 29503202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID.
    Roca C; Motas S; Marcó S; Ribera A; Sánchez V; Sánchez X; Bertolin J; León X; Pérez J; Garcia M; Villacampa P; Ruberte J; Pujol A; Haurigot V; Bosch F
    Hum Mol Genet; 2017 Apr; 26(8):1535-1551. PubMed ID: 28334745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency.
    Tordo J; O'Leary C; Antunes ASLM; Palomar N; Aldrin-Kirk P; Basche M; Bennett A; D'Souza Z; Gleitz H; Godwin A; Holley RJ; Parker H; Liao AY; Rouse P; Youshani AS; Dridi L; Martins C; Levade T; Stacey KB; Davis DM; Dyer A; Clément N; Björklund T; Ali RR; Agbandje-McKenna M; Rahim AA; Pshezhetsky A; Waddington SN; Linden RM; Bigger BW; Henckaerts E
    Brain; 2018 Jul; 141(7):2014-2031. PubMed ID: 29788236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transduction of neurons lining the cerebral external capsules in mice with feline immunodeficiency virus based vectors.
    Alisky JM; Hughes SM; Davidson BL
    Neurosci Lett; 2003 Nov; 351(2):120-4. PubMed ID: 14583396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced secretion and uptake of beta-glucuronidase improves adeno-associated viral-mediated gene therapy of mucopolysaccharidosis type VII mice.
    Elliger SS; Elliger CA; Lang C; Watson GL
    Mol Ther; 2002 May; 5(5 Pt 1):617-26. PubMed ID: 11991753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.